CAMK2G and cardiac hypertrophy: CAMKII inhibits class IIa HDACs, such as HDAC4 and HDAC5, which are known to prevent cardiac hypertrophy by suppressing the expression of myocyte enhancer factor-2 (MEF2), a prohypertrophic transcription factor.